12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Aridis Pharmaceuticals ARDS stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8 million.
  • Cassava Sciences SAVA stock increased by 41.5% to $52.03. The company's market cap stands at $2.0 billion.
  • Quoin Pharmaceuticals QNRX shares rose 40.54% to $2.6. The market value of their outstanding shares is at $21.6 million.
  • Biofrontera BFRI stock moved upwards by 19.16% to $9.08. The market value of their outstanding shares is at $131.2 million.
  • Aditxt ADTX shares moved upwards by 12.92% to $0.7. The market value of their outstanding shares is at $30.4 million.
  • Evofem Biosciences EVFM shares rose 11.41% to $0.41. The company's market cap stands at $67.3 million.
  •  

Losers

  • Aldeyra Therapeutics ALDX shares fell 37.73% to $4.44 during Tuesday's pre-market session. The market value of their outstanding shares is at $257.9 million.
  • Aquestive Therapeutics AQST shares declined by 29.1% to $4.41. The market value of their outstanding shares is at $177.1 million.
  • DBV Technologies DBVT shares fell 20.38% to $2.15. The market value of their outstanding shares is at $236.4 million.
  • CytomX Therapeutics CTMX shares declined by 17.21% to $5.34. The market value of their outstanding shares is at $348.4 million.
  • Kala Pharmaceuticals KALA shares declined by 8.03% to $1.26. The company's market cap stands at $82.5 million.
  • Genfit GNFT stock declined by 7.44% to $5.23. The market value of their outstanding shares is at $239.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...